VTRS लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

बेचें 261 min ago

@ $11.74

जारी किया गया: 4 May 2024 @ 00:38

वापसी: 0.38%

पिछला सिग्नल: May 2 - 23:11

पिछला सिग्नल: खरीदें

वापसी: 0.95 %

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:30):

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets...

Stats
आज की मात्रा	5.02M
औसत मात्रा	9.00M
बाजार मूल्य	14.03B
EPS	$0 ( 2024-02-28 )
अगली कमाई की तारीख	( $0 ) 2024-05-06
Last Dividend	$0.120 ( 2023-11-22 )
Next Dividend	$0 ( N/A )
P/E	235.60
ATR14	$0.235 (1.99%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Le Goff Corinne	Buy	110 162	Restricted Stock Units
2024-04-18	Le Goff Corinne	Buy	78 688	Restricted Stock Units
2024-04-15	Le Goff Corinne	Buy	0
2024-04-02	Malik Rajiv	Buy	18 845	Restricted Stock Units
2024-03-13	Mauro Anthony	Sell	250 000	Common Stock

INSIDER POWER
9.40
Last 99 transactions
Buy: 1 339 847 \| Sell: 1 117 278

मात्रा सहसंबंध

लंबा: 0.85 (strong)

छोटा: 0.23 (neutral)

Signal:(56) Neutral

Viatris Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
MMAC	0.897
NETE	0.888
TMCI	0.868
FCRD	0.864
IGMS	0.862
LNSR	0.849
ISEM	0.849
ARVN	0.836
SRAC	0.833
GANX	0.833

10 सबसे अधिक नकारात्मक सहसंबंध
SVOK	-0.94
RMRM	-0.933
PAIC	-0.907
SVAC	-0.9
FEYE	-0.846
TLGT	-0.841
GOODM	-0.837
SPRT	-0.83
FTOCU	-0.823
BFRI	-0.817

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Viatris Inc. सहसंबंध - मुद्रा/वस्त्र

0.14
( neutral )

0.62
( weak )

0.00
( neutral )

0.01
( neutral )

-0.58
( weak negative )

-0.81
( strong negative )

Viatris Inc. वित्तीय

Annual	2023
राजस्व:	$15.38B
सकल लाभ:	$6.57B (42.70 %)
EPS:	$0.0456

FY	2023
राजस्व:	$15.38B
सकल लाभ:	$6.57B (42.70 %)
EPS:	$0.0456

FY	2022
राजस्व:	$16.26B
सकल लाभ:	$6.50B (39.95 %)
EPS:	$1.710

FY	2021
राजस्व:	$17.89B
सकल लाभ:	$5.58B (31.17 %)
EPS:	$-2.11

Financial Reports:

No articles found.

Viatris Inc. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.240 (N/A)	$0.120 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Viatris Inc. Dividend Information - Dividend King

Dividend Sustainability Score: 6.81 - average (93.69%) | Divividend Growth Potential Score: 4.62 - Stable (7.56%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.00741	1986-12-24
Last Dividend	$0.120	2023-11-22
Next Dividend	$0	N/A
Payout Date	2023-12-15
Next Payout Date	N/A
# dividends	88	--
Total Paid Out	$2.99	--
Avg. Dividend % Per Year	2.32%	--
Score	5.02	--
Div. Sustainability Score	6.81
Div.Growth Potential Score	4.62
Div. Directional Score	5.72	--

Next Divdend (Est)
(2024-06-03)

$0.123 Estimate 35.64 %

Dividend Stability

0.71 Good

Dividend Score

5.02

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1986	$0.00741	0.28%
1987	$0.0148	0.88%
1988	$0.0111	0.86%
1989	$0.0148	1.13%
1990	$0.0222	0.63%
1991	$0.0296	1.01%
1992	$0.0326	0.53%
1993	$0.0416	0.46%
1994	$0.0564	0.78%
1995	$0.0652	0.85%
1996	$0.0712	0.70%
1997	$0.0712	0.97%
1998	$0.0712	0.80%
1999	$0.0712	0.53%
2000	$0.0712	0.66%
2001	$0.0712	0.65%
2002	$0.0756	0.47%
2003	$0.0966	0.61%
2004	$0.120	0.48%
2005	$0.210	1.20%
2006	$0.240	1.20%
2007	$0.120	0.60%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0.330	1.78%
2022	$0.480	3.38%
2023	$0.600	5.27%
2024	$0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.00355	1.500	9.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.00115	1.200	9.96	10.00	[0 - 0.3]
returnOnEquityTTM	0.00263	1.500	-1.082	-1.623	[0.1 - 1]
payoutRatioTTM	10.52	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.572	0.800	7.14	5.71	[1 - 3]
quickRatioTTM	0.658	0.800	-0.833	-0.666	[0.8 - 2.5]
cashRatioTTM	0.128	1.500	-0.401	-0.602	[0.2 - 2]
debtRatioTTM	0.382	-1.500	3.63	-5.45	[0 - 0.6]
interestCoverageTTM	1.886	1.000	-0.413	-0.413	[3 - 30]
operatingCashFlowPerShareTTM	2.33	2.00	9.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.937	2.00	9.03	10.00	[0 - 20]
debtEquityRatioTTM	0.890	-1.500	6.44	-9.66	[0 - 2.5]
grossProfitMarginTTM	0.419	1.000	6.36	6.36	[0.2 - 0.8]
operatingProfitMarginTTM	0.0708	1.000	-0.585	-0.585	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.154	1.000	-0.257	-0.257	[0.2 - 2]
assetTurnoverTTM	0.323	0.800	-1.178	-0.943	[0.5 - 2]
Total Score				6.81

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	254.50	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.00263	2.50	-0.695	-1.623	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.937	2.00	9.35	10.00	[0 - 30]
dividendYielPercentageTTM	4.14	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.33	2.00	9.22	10.00	[0 - 30]
payoutRatioTTM	10.52	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-1.597	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.182	1.000	7.96	0	[0.1 - 0.5]
Total Score				4.62

Viatris Inc.

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.

के लिए वास्तविक समय के अद्यतन Viatris Inc. [VTRS]

Upcoming Earnings Alert

Viatris Inc. Dividend Information - Dividend King

Dividend Commentary

Top 10 dividend Companies for NASDAQ

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)